We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-1.25%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$245M
AUM Growth
Cap. Flow
+$236M
Cap. Flow %
96.31%
Top 10 Hldgs %
24.22%
Holding
298
New
298
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 14.38%
2 Energy 12.91%
3 Consumer Discretionary 11.94%
4 Industrials 11.85%
5 Real Estate 10.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLM icon
276
SLM Corp
SLM
$4.89B
$163K 0.07%
+25,706
New +$155K
BDN
277
Brandywine Realty Trust
BDN
$524M
$157K 0.06%
+11,175
New +$143K
ARCC icon
278
Ares Capital
ARCC
$13.5B
$154K 0.06%
+10,379
New +$143K
XIN
279
DELISTED
Xinyuan Real Estate
XIN
$150K 0.06%
+3,390
New +$127K
NYT icon
280
New York Times
NYT
$12.1B
$144K 0.06%
+11,594
New +$147K
OPK icon
281
Opko Health
OPK
$985M
$141K 0.06%
+13,609
New +$124K
LXP icon
282
LXP Industrial Trust
LXP
$3.57B
$131K 0.05%
+3,051
New +$117K
DDC
283
DELISTED
Dominion Diamond Corporation
DDC
$131K 0.05%
+11,820
New +$129K
BVN icon
284
Compañía de Minas Buenaventura
BVN
$7.69B
$115K 0.05%
+15,700
New +$79K
ACHN
285
DELISTED
Achillion Pharmaceuticals
ACHN
$101K 0.04%
+13,039
New +$95.5K
TRIL
286
DELISTED
Trillium Therapeutics Inc.
TRIL
$100K 0.04%
+10,841
New +$91.4K
TPST icon
287
Tempest Therapeutics
TPST
$13.7M
$95K 0.04%
+3
New +$63.4K
FOLD
288
DELISTED
Amicus Therapeutics
FOLD
$93K 0.04%
+11,022
New +$78.1K
PACB icon
289
Pacific Biosciences
PACB
$435M
$85K 0.03%
+10,000
New +$98.3K
CRDF icon
290
Cardiff Oncology
CRDF
$66.5M
$81K 0.03%
+241
New +$82K
PTCT icon
291
PTC Therapeutics
PTCT
$5.64B
$72K 0.03%
+11,211
New +$195K
NVIV
292
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$70K 0.03%
+1
New +$107K
ARIA
293
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$64K 0.03%
+10,000
New +$56K
TVRD
294
Tvardi Therapeutics
TVRD
$19.7M
$62K 0.03%
+278
New +$83K
SSRI
295
DELISTED
Silver Standard Resources
SSRI
$58K 0.02%
+10,441
New +$55.1K
ADVM
296
DELISTED
Adverum Biotechnologies
ADVM
$52K 0.02%
+1,000
New +$55.8K
SGYP
297
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$45K 0.02%
+16,379
New +$59.3K
RXII
298
DELISTED
GALENA BIOPHARMA INC COM
RXII
$14K 0.01%
+10,000
New +$14K

Similar funds

Schonfeld Strategic Advisors's Q1 2016 Portfolio in Review

Q1 2016 is the first quarter with a 13F filing on record for Schonfeld Strategic Advisors, which disclosed 298 positions worth $245M. Its ten largest holdings account for 24% of the portfolio.

Its largest position is STORE Capital Corporation: 488,518 shares worth $12.6M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, followed by Energy and Consumer Discretionary.

  • Schonfeld Strategic Advisors's largest Q1 2016 buy was STORE Capital Corporation: 488,518 shares worth $12.6M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 24% of its $245M portfolio in Q1 2016.
  • Schonfeld Strategic Advisors disclosed 298 positions in Q1 2016, its first 13F filing on record.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2016, filed 16 May 2016.